PRRT Treatment Centre Rotterdam (an Erasmus MC initiative) is the internationally highly regarded treatment and knowledge centre for PRRT (Peptide Receptor Radionuclide Therapy). PRRT focuses on the extension and improvement of the quality of life of patients with neuroendocrine tumours. Specialists also find specific knowledge and information here.
PRRT Treatment Centre Rotterdam has been treating patients with neuroendocrine tumors (NET) and other rare forms of cancer since 2000. PRRT is a therapy with the radioactively labeled protein Lutetium-177-Octreotate which allows these rare tumours to be treated with precision. The results are therefore generally very good.